Cargando…
Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632669/ https://www.ncbi.nlm.nih.gov/pubmed/34785794 http://dx.doi.org/10.1038/s41375-021-01357-4 |
| _version_ | 1784607794418155520 |
|---|---|
| author | Mai, Elias K. Miah, Kaya Bertsch, Uta Dürig, Jan Scheid, Christof Weisel, Katja C. Kunz, Christina Munder, Markus Lindemann, Hans-Walter Merz, Maximilian Hose, Dirk Jauch, Anna Seckinger, Anja Luntz, Steffen Sauer, Sandra Fuhrmann, Stephan Brossart, Peter Elmaagacli, Ahmet Goerner, Martin Bernhard, Helga Hoffmann, Martin Raab, Marc S. Blau, Igor W. Hänel, Mathias Benner, Axel Salwender, Hans J. Goldschmidt, Hartmut |
| author_facet | Mai, Elias K. Miah, Kaya Bertsch, Uta Dürig, Jan Scheid, Christof Weisel, Katja C. Kunz, Christina Munder, Markus Lindemann, Hans-Walter Merz, Maximilian Hose, Dirk Jauch, Anna Seckinger, Anja Luntz, Steffen Sauer, Sandra Fuhrmann, Stephan Brossart, Peter Elmaagacli, Ahmet Goerner, Martin Bernhard, Helga Hoffmann, Martin Raab, Marc S. Blau, Igor W. Hänel, Mathias Benner, Axel Salwender, Hans J. Goldschmidt, Hartmut |
| author_sort | Mai, Elias K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8632669 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86326692021-12-15 Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age Mai, Elias K. Miah, Kaya Bertsch, Uta Dürig, Jan Scheid, Christof Weisel, Katja C. Kunz, Christina Munder, Markus Lindemann, Hans-Walter Merz, Maximilian Hose, Dirk Jauch, Anna Seckinger, Anja Luntz, Steffen Sauer, Sandra Fuhrmann, Stephan Brossart, Peter Elmaagacli, Ahmet Goerner, Martin Bernhard, Helga Hoffmann, Martin Raab, Marc S. Blau, Igor W. Hänel, Mathias Benner, Axel Salwender, Hans J. Goldschmidt, Hartmut Leukemia Correction Nature Publishing Group UK 2021-11-16 2021 /pmc/articles/PMC8632669/ /pubmed/34785794 http://dx.doi.org/10.1038/s41375-021-01357-4 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Mai, Elias K. Miah, Kaya Bertsch, Uta Dürig, Jan Scheid, Christof Weisel, Katja C. Kunz, Christina Munder, Markus Lindemann, Hans-Walter Merz, Maximilian Hose, Dirk Jauch, Anna Seckinger, Anja Luntz, Steffen Sauer, Sandra Fuhrmann, Stephan Brossart, Peter Elmaagacli, Ahmet Goerner, Martin Bernhard, Helga Hoffmann, Martin Raab, Marc S. Blau, Igor W. Hänel, Mathias Benner, Axel Salwender, Hans J. Goldschmidt, Hartmut Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age |
| title | Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age |
| title_full | Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age |
| title_fullStr | Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age |
| title_full_unstemmed | Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age |
| title_short | Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age |
| title_sort | publisher correction: bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632669/ https://www.ncbi.nlm.nih.gov/pubmed/34785794 http://dx.doi.org/10.1038/s41375-021-01357-4 |
| work_keys_str_mv | AT maieliask publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT miahkaya publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT bertschuta publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT durigjan publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT scheidchristof publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT weiselkatjac publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT kunzchristina publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT mundermarkus publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT lindemannhanswalter publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT merzmaximilian publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT hosedirk publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT jauchanna publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT seckingeranja publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT luntzsteffen publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT sauersandra publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT fuhrmannstephan publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT brossartpeter publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT elmaagacliahmet publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT goernermartin publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT bernhardhelga publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT hoffmannmartin publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT raabmarcs publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT blauigorw publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT hanelmathias publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT benneraxel publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT salwenderhansj publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT goldschmidthartmut publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage AT publishercorrectionbortezomibbasedinductionhighdosemelphalanandlenalidomidemaintenanceinmyelomaupto70yearsofage |